Back to mobile site

Contineum Therapeutics, Inc. (CTNM) Misses Q4 EPS by 11c

March 7, 2025 6:18 AM EST

Contineum Therapeutics, Inc. (NASDAQ: CTNM) reported Q4 EPS of ($0.56), $0.11 worse than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Contineum Therapeutics, Inc. (CTNM) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK